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The development of follicles from the antral to the preovulatory stage in the mammalian ovary involves both proliferation
and differentiation of cells. These processes are coordinated by endocrine, paracrine, and autocrine factors in a time- and
cell-speci®c pattern. Each stage of development is characterized by expression of speci®c genes the products of which
are involved in different cellular processes, e.g., signal transduction (cAMP-dependent protein kinases), steroidogenesis
(cytochrome P450 enzymes). At the nuclear level, the signaling pathway from external stimuli converges to modify the
mechanisms of transcription factors. One such factor, CCAAT enhancer binding protein-a (C/EBPa), participates in differen-
tiation processes of several organs, e.g., liver, adipose tissue, and gut. We have previously demonstrated that C/EBPa is
expressed in rat ovarian follicles in a cell-, time-, and hormone-speci®c manner. This increase in granulosa cells was
concomitant with the more differentiated phenotype. The aim of the present study was to explore the function of C/EBPa
in the rat ovary. To achieve this, the expression of C/EBPa in follicular cells was attenuated in vivo by the local administra-
tion of antisense oligonucleotides (AS) into the ovarian bursa, i.e., the sac-like structure surrounding the ovary of immature
rats. This administration resulted in an impaired response to subsequent injections of exogenous gonadotropins (PMSG,
hCG) with an attenuated expression of C/EBPa protein and ®nally a decreased ovulation rate. Furthermore, the morphology
of the AS-treated ovary was altered with large, oocyte-containing follicles at a time when ovaries exposed to sense (S)
oligonucleotides demonstrated newly formed corpora lutea. AS also affected the expression of the proto-oncogene c-myc,
which was elevated by this treatment. The administration of S was without effects. Thus, C/EBPa seems to be a necessary
factor for follicular development in the rat ovary. q 1996 Academic Press, Inc.
INTRODUCTION are associated with the specialized functions of the differen-
tiated phenotype, e.g., receptors for luteinizing hormone
(LH) (Segaloff et al., 1990), enzymes involved in steroidogen-The preovulatory follicle in the mammalian ovary pro-
esis (P450scc , P45017a-OH, P450arom) (Hedin et al., 1987a;vides the external milieu for the oocyte prior to ovulation
Hickey et al., 1988), and intracellular signaling systemsand fertilization. To reach this stage of development, the
(protein kinase A) (Hedin et al., 1987b).granulosa and theca cells of the follicles have passed several
In a previous study (Piontkewitz et al., 1993), the expres-cycles of proliferation from the primordial follicle to the
sion of the transcription factor CCAAT enhancer bindingantral stage (Hirsh®eld and Schmidt, 1987). The subsequent
protein-a (C/EBPa) was demonstrated in mature granulosadevelopment from the antral to the preovulatory stage in-
cells of rat preovulatory follicles. Furthermore, the expres-volves both proliferation and differentiation of cells. Several
sion of C/EBPawas augmented with the increasing stages ofstudies have demonstrated requirements of steroids (estra-
follicular development and was regulated by gonadotropinsdiol) and gonadotropins (follicle-stimulating hormone, FSH)
(PMSG) and steroids (estradiol). These ®ndings implicatedin the latter part of development prior to the preovulatory
C/EBPa as an important, intracellular regulator of follicularstage (Richards, 1994). There are increases in several ovar-
development. We therefore decided to examine the role ofian-speci®c proteins in granulosa cells and these proteins
C/EBPa during follicular development in vivo. The ap-
proach was to decrease the expression of the protein by the
administration of antisense oligonucleotides to C/EBPa. In1 Present address: Department of Science Education, Biology, The
Weizmann Institute, Rehovot, Israel. order to selectively decrease the levels of C/EBPa in the
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mined as the number of ovulated oocytes retrieved from the ovi-ovary without affecting its expression in other organs, e.g.,
duct 20 hr after hCG.liver (Mischoulon et al., 1992), gut (Chandrasekaran and
Gordon, 1993), and adipose tissue (Lin and Lane, 1992), we
took advantage of a particular anatomical feature of the Solution Hybridization Assayrat ovary, namely, the sac-like structure of the oviductal
Ovaries were homogenized by a Polytron (Brinkmann Instru-mesentery, the ovarian bursa. Buffered solutions containing
ments, Westbury, NY) in buffer containing 1% sodium dodecylsense or antisense oligonucleotides were injected into the
sulfate (SDS), 20 mM Tris±HCl (pH 7.5), and 10 mM EDTA. Thespace between the bursa and the surface of the ovary
tissues were then digested with proteinase-K for 24 hr at roomthrough laparotomy in anesthetized animals. This enabled
temperature and extracted with phenol±chloroform. Each sampleus to study the biological function(s) of C/EBPa speci®cally
with total nucleic acids (TNA) was prepared from tissues takenin the ovary with a minimum of interference with its ex-
from three different animals and the amount of DNA was measured
pression in other organs. The bursa of the rat ovary has with a ¯uorometer (TKO-100, Hoeffer Scienti®c Instruments, San
previously been used for local deposition of pharmacologi- Francisco, CA). Each sample contained 2±4 mg/ml of DNA (Piont-
cal substances or antibodies to study short-term effects (up kewitz et al., 1993).
to 20 hr) on the ovulatory process (Reich et al., 1985; Tsafriri C/EBPa and c-myc mRNA were quanti®ed by solution hybridiza-
tion assays as described by Durnam and Palmiter (1983). Brie¯y,et al., 1989). In the present study we exploited this possibil-
the probes and mRNA were prepared according to the protocolity to affect long-term (up to 72 hr) processes in vivo initi-
provided by the manufacturer of the p4Zm plasmid (Promega, Mad-ated at the nuclear level by the deposition of oligonucleo-
ison, WI). The antisense RNA probe were generated with T7 poly-tides into the ovarian bursa of immature animals prior to
merase (Promega, Madison, WI). Both these assays have been de-hormonal treatment to initiate follicular development and
scribed in detail elsewhere (Samuelsson et al., 1991; Piontkewitzovulation. The effect of antisense treatment was registered
et al., 1993).
as the ability of the immature rat ovary to develop in re- TNA samples were obtained from three independent experi-
sponse to exogenous gonadotropins and ®nally to ovulate. ments. The TNA sample from each group and time point was ana-
lyzed in triplicate. The mean was calculated from the triplicate
assay and used as a single value in the subsequent analysis. The
within-assay coef®cient of variation was approximately 15%.MATERIALS AND METHODS
Statistical AnalysisAnimals and Surgical Procedure
Statistical evaluation were performed using a one-way analysisTwenty-®ve-day old rats (Sprague±Dawley) were anesthetized
of variance (ANOVA), followed by Student±Neuman±Kuels test.with Ketalar/Rompun ip (67 mg/kg Ketalar, Parke-Davis, Morris
A P-value .05 was considered signi®cant (Woolf, 1968).Plains, NJ, and 13 mg/kg Rompun, Bayer, Leverkusen, Germany).
The ovaries were exposed through laparotomy. The different treat-
ment solutions (PBS or sense (S) or antisense (AS) oligonucleotides)
Histology and Immunohistochemistrywere injected into the bursa, i.e., the space between the mesothe-
lium surrounding the ovary and its surface, with a syringe (32 gauge) Ovaries were dissected free of adherent adipose tissue and incu-
(Hamilton, Bonaduz, Switzerland) under the guidance of a dissec- bated in 4% paraformaldehyde±PBS for 4 hr. For histology these
tion microscope (Zeiss, Germany). Both ovaries in each animal ovaries were routinely ®xed and paraf®n-embedded. The sections
received the same solution. The incisions were closed with ®ne (20 mm) were stained with hematoxylin and the sections were ex-
sutures. amined in a light microscope.
For immunohistochemistry, the ovaries were transferred to 15%
sucrose at 47C o/n after the initial incubation in 4% paraformalde-
hyde/phosphate-buffered saline (PBS). The tissue was embedded inHormonal Treatments, Analysis of Tissues, Serum,
Tissue-Tek II OCT compound (Miles, Elkhart, IN) and frozen inand Ovulation Rate
isopentane (in liquid nitrogen). Cryosections (thickness 10 mm,
Leitz cryostat, Rockleigh, NJ) were placed on slides precoated withTwo hours after surgery, the animals received 10 IU of pregnant
mare's serum gonadotropin (PMSG) sc to initiate follicular growth poly-L-lysine (0.1%) (Sigma, St. Louis, MO) and thereafter were
hydrated with cold PBS and permeabilized for 30 min at room tem-(Ekholm and HillensjoÈ , 1982). Forty-eight hours later, speci®c
groups of animals were injected with 10 IU of human chorionic perature in PBS containing 0.05% Triton X-100 and 1% BSA before
incubation with the ®rst antibody. The sections were incubated o/ngonadotropin (hCG) ip to imitate the ovulatory surge of luteiniz-
ing hormone (LH). Whole ovaries, isolated oocytes, and granulosa at 47C with a polyclonal antiserum directed against C/EBPa (kindly
provided by Drs. J. E. Danell Jr., S. L. McKnight, and K. G. Xanto-cells were obtained 24 hr after PMSG, and whole ovaries 48 hr
after PMSG. In addition, whole ovaries were also dissected 20 hr poulos) raised in rabbits. The antiserum was diluted 1:200 in PBS
containing 0.05% Triton X-100 and 1% BSA. After rinsing threeafter hCG. The ovarian tissues were analyzed for the presence of
C/EBPamRNA (solution hybridization), protein (immunoblotting times in PBS, the slides were incubated for 1 hr at room temperature
with FITC-conjugated goat anti-rabbit antibodies (Kemila, Sweden)and immunohistochemistry), and morphology. Livers were ob-
tained at 24 and 48 hr after PMSG for analysis by immunoblotting. and then washed four times in PBS and mounted with Moviol/
Dabco mounting medium (0.4% Moviol, Hoechst AG, Germany)The serum levels of progesterone and estradiol were measured by
RIA (Spectria, Orion Diagnostica, Espoo, Finland) at 24 and 48 hr in 30% glycerol with the addition of 2.5% Dabco (4-diazabi-
cyclo(2.2.2)octane; Fluka, Buchs, Switzerland). Control stainingafter PMSG and 20 hr after hCG. The ovulation rate was deter-
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with normal serum or second antibody only demonstrated negligi- genes in nonproliferating hepatocytes (Friedman et al., 1989).
ble signals (data not shown). All sections were analyzed with a Its essential role for the development and function of liver
¯uorescence microscope (Piontkewitz et al., 1993). and adipose tissues was recently described in mice homozy-
gous for the targeted deletion of the C/EBPa gene. These mice
Immunoblotting demonstrated failure to accumulate lipid and to maintain
energy homeostasis after birth (Wang et al., 1995).Soluble tissue extracts were prepared by homogenization in a
The accumulated data for a critical role of C/EBPa inphosphate/EDTA buffer (10 mM potassium phosphate, pH 6.8, 1
mM EDTA) containing 10 mM 3-[(3-cholamidopropyl) dimethylam- liver-speci®c processes suggested to us to initially examine
monio]-1-propane sulfonate (Chaps, Boehringer, Germany) and if the intrabursal route of administration of oligonucleo-
Aprotinin (200 IE kallikrein inhibiting units/ml, Boehringer, Ger- tides affected expression in the liver. Therefore, soluble cell
many). The homogenate was then sonicated (21 15 sec) and centri- extracts were prepared from livers of animals receiving in-
fuged (12,000g, 5 min), supernatants being stored at 0707C until trabursal injections (20 ml of a 600 mM solution into each
analysis. The samples were diluted in SDS sample buffer before
bursa) of S or AS oligonucleotides to C/EBPa. Thereafter (2loading on 1D SDS±PAGE (14% separating gel, Novex, San Diego,
hr after surgery), the animals were injected with PMSG (10CA). The amount of total protein was 50 mg per lane. The proteins
IU sc) to initiate follicular growth in the ovary (Ekholm andwere transferred to a PVDF membrane (Millipore, Bedford, MA) by
HillensjoÈ , 1982). The livers were exstirpated 24 and 48 hrelectroblotting (Novex), after which the membrane was incubated
after the injection of PMSG. The cell extracts were exam-with antiserum against C/EBPa (see above, dilution 1:1,000) or a
monoclonal antibody against c-myc (Santa Cruz Biotechnology, ined by immunoblotting using an antiserum against C/
Santa Cruz, CA, dilution 1:500). Immunoreactive protein was visu- EBPa. No changes in the expression of C/EBPa could be
alized by chemiluminescence using an alkaline phosphatase-conju- detected between S- and AS-treated animals at 24 or 48 hr
gated second antibody and AMPPD as substrate (Tropix, Bedford, (data not shown). Thus, the systemic effects of AS adminis-
MA) (Bronstein et al., 1992; Piontkewitz et al., 1993). The mem- tration were undetectable.
branes were exposed to ECL ®lm (Amersham, UK) at room tempera-
ture for 1±4 min. Equal loading of gels was ensured by staining
with copper solution (Bio-Rad, Richmond, CA) prior to transfer and Ovaries Treated with Antisense Oligonucleotides
staining of gels after transfer (Coomassie blue). Membranes were to C/EBPa Demonstrated an Altered Morphology
stained with India ink after immunodetection to further evaluate
The ®nal stage of follicular development is initiated bythe ef®ciency of transfer.
the ovulatory surge of LH which activates a cascade of
events including biochemical and morphological changesOligonucleotides
in preovulatory follicles resulting in rupture of the follicularThe S and AS phosphorothioated oligonucleotides were synthe-
wall, expulsion of the oocyte, and the formation of the cor-sized on a 380A DNA synthesizer (Applied Biosystems, Foster City,
pus luteum. Earlier studies (Piontkewitz et al., 1993) dem-CA) using b-cyanoethylphosphoramidite chemistry and tetraethyl-
onstrated an increase of C/EBPa mRNA and protein inthiuram disul®de as sulfurizing reagent. Puri®cation was per-
small, antral follicles of immature ovaries after the adminis-formed by HPLC (Merck-Hitachi, Japan) using reverse-phase trity-
lon chromatography (Department of Medical Immunology and Mi- tration of PMSG. The level of C/EBPa increased with follic-
crobiology, Uppsala University, Sweden). ular growth and differentiation with maximal level at the
The AS consisted of a equimolar mixture of two modi®ed oligo- preovulatory stage (PO), i.e., 48 hr after the administration
nucleotides (phophorothioated, 18-mer) directed against nucleo- of PMSG. The administration of an ovulatory dose of hCG
tides /1 (the ®rst base of the rat C/EBPa mRNA) to /18 (5* CTT ip, mimicking the endogenous LH surge, resulted in a dra-
TGG GTC GCG AAT GGC 3*) and nucleotides /118 to /135 in matic decrease of C/EBPa mRNA. These data suggestedwhich /133 to /135 encodes the initiation ATG (5* CAT GGG
that C/EBPa was involved in the transition of the small,GGA GTT AGA GTT 3*) (Landschultz et al., 1988). The controls
antral follicle to a more differentiated stage, i.e., the POwere the corresponding S oligonucleotides. The mixtures of the
stage, making the follicle capable of responding to the ovu-respective oligonucleotides were dissolved in 20 ml of PBS (pH 7.4)
latory surge of LH.with a ®nal concentration of 600 mM. In initial experiments, a
concentration of 300 mM was found to be without effects on mor- In order to examine the effects of AS on follicular develop-
phology and ovulation rate, and 1200 mM did not demonstrate addi- ment and the subsequent response to LH/hCG, ovaries were
tional effects compared to 600 mM (data not shown). In some experi- examined 20 hr after the administration of an ovulatory
ments the injection of PBS alone served as an additional control dose of hCG (10 IU ip). At this time point, animals injected
group. with PMSG and hCG are expected to contain ovaries with
newly formed corpora lutea and ovulated oocytes in the
oviducts. Ovaries exposed to S oligonucleotides exhibited aRESULTS
normal morphology with several newly formed corpora lu-
Animals Treated with Intrabursal Deposition tea and middle- and small-sized follicles. In contrast, ovaries
of C/EBPa Antisense Oligonucleotides Exhibited exposed to AS oligonucleotides contained few corpora lutea
Unaffected Levels of C/EBPa Protein in Their as a demonstration of a reduced number of ovulations. In
Livers fact, these ovaries contained several large follicles with en-
closed oocytes (Fig. 1). This ®nding therefore suggested thatThe role of C/EBPa has been focused on adipogenesis in
vitro (Yeh et al., 1995) and the regulation of liver-speci®c AS treatment interfered with follicular development re-
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FIG. 1. Morphology of ovaries after treatment with sense (a) or antisense (b) oligonucleotides. The ovaries were obtained 20 hr after an
ovulatory dose of hCG (10 IU ip) to PMSG-primed animals (48 hr after PMSG).
sulting in a failure to ovulate in response to an ovulatory order to quantitate the decrease in content of the C/EBPa
protein. The antiserum for these analyses was the same asdose of hCG.
for the immunohistochemical analysis described above. A
substantial decrease was observed at both 24 and 48 hr in
Reduced Expression of C/EBPa Protein in AS- ovaries receiving AS. The major band had a molecular
Treated Ovaries weight of 42 kDa, as reported previously as the transcrip-
tionally active, monomeric form of the protein (Umek etThe next step was to examine if the observed changes in the
morphology of ovaries treated with AS was due to a reduced al., 1991). Quantitation by densitometric scanning of three
independent blots revealed a decrease to 63 { 8% at 24 hrexpression of C/EBPa protein. Granulosa cells and oocytes
were obtained from follicles 24 hr after PMSG in ovaries (n  3, mean { SD, P  .03) and to 54 { 12% at 48 hr (n
 3, mean { SD, P  .02) compared to S-treated ovaries.pretreated with S or AS (Fig. 2). The cells were stained with
an antiserum against C/EBPa followed by a ¯uorescein-conju- The levels of C/EBPa mRNA was determined by a solution
hybridization assay at different time points after PMSG ingated secondary antibody. The expression of the protein was
reduced in both oocytes and granulosa cells. The staining of ovaries receiving intrabursal injections of buffer only (PBS)
or S or AS oligonucleotides. The mRNA levels increasedthe oocyte from an AS-treated ovary (Fig. 2c) was faint com-
pared to the oocyte exposed to S oligonucleotides (Fig. 2a), in all treatment groups after 12 hr, as reported previously
(Piontkewitz et al., 1993), with a further increase to the POalthough some staining was observed in the surrounding cu-
mulus cells. The staining of the germinal vesicle in the oocyte stage (48 hr after PMSG). The pattern was similar in all
three groups and they were not signi®cantly different fromwas distinct, whereas the cytoplasm demonstrated a less in-
tense and more diffuse pattern. Also, the granulosa cells of each other at any of the speci®c time points (data not
shown). This ®nding was in contrast to the protein levelsthese follicles exhibited a pronounced decrease in staining for
C/EBPa (Fig. 2d) compared to those of S-treated follicles (Fig. which were reduced at both 24 and 48 hr after PMSG.
2b). Granulosa cells obtained from ovaries receiving PBS only
exhibited the same staining pattern as the S-treated group
Antisense Treatment Results in a Reduced(data not shown).
Ovulation RateSections of ovaries obtained at 24 (Figs. 3a and 3c) and 48
(Figs. 3b and 3d) hr were positively stained with antiserum The previous experiments had demonstrated changes in
AS-treated ovaries with morphological signs of unrupturedagainst C/EBPa. The antral follicles in ovaries at 24 hr after
S administration demonstrated a clear staining of the granu- follicles 20 hr after an ovulatory dose of hCG (Fig. 1). To
quantitate this effect, the number of ovulated oocytes waslosa cells and to some extent also of the interstitial tissue,
whereas the thecal layer gave no signal (Fig. 3a). Exposure counted in the oviduct in three treatment groups: animals
receiving buffer only (PBS) or S or AS oligonucleotides. Theto AS resulted in a faint signal of the granulosa cells, while
the signal of the interstitial cells was unaltered (Fig. 3c). At number of ovulated oocytes was determined 20 hr after the
injection of hCG, i.e., approximately 8 hr after the expected48 hr after exposure to S, the granulosa cells of the preovula-
tory follicles exhibited an intense signal (Fig. 3b), while AS ruptures of follicles.
The ovulation rates in animals receiving intrabursal in-decreased the signal substantially (Fig. 3d). However, the
inner mural layers of antral follicles demonstrated some jections of either PBS alone or S were similar (Fig. 5). The
number of ovulations in these two groups was in the samepositive staining.
Immunoblotting was performed with extracts of ovaries range as that in animals receiving the same hormonal treat-
ment but without the surgical stress (laparotomy/intrabur-obtained at 24 (Fig. 4a) and 48 (Fig. 4b) hr after PMSG in
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FIG. 2. Oocytes (a, c) and granulosa cells (b, d) from antral follicles 24 hr after PMSG. The animals received intrabursal injections of
sense (a, b) or antisense (c, d) oligonucleotides to C/EBPa.
sal injections) (data not shown). However, the number of EBPa expression. This block in differentiation was over-
come by a forced expression of C/EBPa.ovulated oocytes was substantially reduced to approxi-
mately 50% in ovaries exposed to AS compared to the other We were therefore interested to examine if a similar, re-
ciprocal relationship between these two transcription fac-treatment groups (P  0.004).
Since the synthesis of steroids is an important indicator tors also existed in vivo in ovarian cells. In contrast to C/
EBPa, which was reduced at 48 hr in AS-compared to S-of follicular function, the serum levels of progesterone and
estradiol were determined in the three groups at 24 and 48 treated ovaries (Fig. 4b), the content of c-myc protein was
increased (Fig. 6). Quantitation by densitometric scanninghr after PMSG. The levels of progesterone were unchanged
from 24 to 48 hr in the group receiving PBS only (0.79 { of three independent blots revealed an increase to 129 {
4% at 48 hr (n  3, mean { SD, P  .01) compared to S-0.21 nmole/liter (24 hr), 0.8 { 0.36 nmole/liter (48 hr) (n 
4, mean { SD)). At these time points the levels of estradiol treated ovaries. In parallel, the level of c-myc mRNA was
elevated in AS ovaries at 24 hr (P  0.05) and at 48 hr (P were 2.49 { 0.54 and 2.79 { 0.59 pmole/liter, respectively.
The levels after S and AS treatment were similar, and no 0.05) compared to S- and PBS-treated animals. The two lat-
ter groups demonstrated an initial increase of c-myc mRNAstatistical differences could be observed (data not shown).
followed by a decrease prior to a second increase at the PO
stage (Fig. 7).
The Reduced Expression of C/EBPa Evokes an
Increase in the Protooncogen c-myc
DISCUSSIONExperimental studies in vitro using cell lines have sug-
gested an antagonistic relationship between C/EBPa and c-
myc. Freytag and Geddes (1992) demonstrated that elevated This study demonstrates that C/EBPa has a crucial role
in the late phase of follicular development in the rat ovary,expression of c-myc was associated with an inability of pre-
adipocytes to differentiate into adipocytes and to repress C/ i.e., from the antral to the PO stage. To reach this latter
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FIG. 3. Sections of ovaries at 24 hr (a, c) and 48 hr (b, d) after PMSG. The animals received intrabursal injections of sense (a, b) or
antisense (c, d) oligonucleotides to C/EBPa. The sections were stained with antiserum to C/EBPa.
stage, which represents the fully differentiated follicle, a strated the dif®culties to study the role of C/EBPa at later
(postnatal) stages of development of organs due to the pro-complex interplay of endocrine, paracrine, and autocrine
factors is needed. In the present study, small antral follicles found effects on metabolism and survival. This disadvan-
tage could be circumvented by a combination of homolo-were triggered to develop by the injection of PMSG, which
has a mainly FSH-like activity in the rat. This results in gous recombination and site-speci®c recombination using
bacteriophages, although the use and success of this tech-the stimulation of steroidogenesis in granulosa cells and
®nally, in concert with theca cells, the production of estra- nique is still very limited (Chambers, 1994).
The aim of intrabursal deposition of AS oligonucleotidesdiol (Richards, 1994). The combined activity of FSH and
estradiol results in the expression of several proteins which was to limit the cellular action to the ovary. A localized
effect was of utmost importance since C/EBPa has beenare associated with the differentiated phenotype in granu-
losa cells, e.g., the regulatory subunit of cAMP-dependent demonstrated to transactivate several liver speci®c genes,
e.g., albumin (Nerlov and Ziff, 1994), ceruloplasmin (Bingleprotein kinase type II (RIIb; Hedin et al., 1987b) and the LH
receptor (Segaloff et al., 1990). We have previously demon- et al., 1993), and apolipoprotein (Carlsson et al., 1990).
Thus, it is very likely that secondary ``metabolic effects''strated a parallel expression of C/EBPa and the process of
differentiation in granulosa cells to the PO stage (Piontkew- due to an altered metabolism in liver and adipose tissue
would dominate if C/EBPa expression was to be extin-itz et al., 1993). In the present study, the aim was to evaluate
the functional role of this transcription factor in the ``termi- guished in a gene targeting experiment. In fact, mice homo-
zygous for the targeted deletion of the c/ebpa gene did notnal'' differentiation process in granulosa cells in vivo.
The role for C/EBPa in the regulation of terminal adipo- store hepatic glycogen and died from hypoglycemia shortly
after birth (Wang et al., 1995). Furthermore, these micegenesis are well described in vitro (Samuelsson et al., 1991;
Lin and Lane, 1992; Yeh et al., 1995). Experiments where failed to accumulate lipids. Although these latter ®ndings
were not known to us during our study, we felt that a strat-the expression of C/EBPa was inhibited by antisense RNA
prevented the terminal differentiation of adipoblastic cell egy to minimize the general effects of an inhibition of C/
EBPa was important. We were unable to detect any differ-lines (Samuelsson et al., 1991; Lin and Lane, 1992). Recent
studies with mice lacking the c/ebpa gene have also demon- ences in the expression of C/EBPa protein in livers from
animals treated with AS or S. We could therefore with astrated abnormalities in the development of adipose tissues
(Wang et al., 1995). However, this latter study also demon- reasonable degree of accuracy rule out any signi®cant, sys-
Copyright q 1996 by Academic Press, Inc. All rights of reproduction in any form reserved.
AID DB 8367 / 6x13$$$742 09-19-96 08:34:51 dbal AP: Dev Bio
294 Piontkewitz, EnerbaÈ ck, and Hedin
FIG. 5. The number of oocytes retrieved from the oviduct in ani-
mals (n  6±8, mean { SD) (20 hr after an ovulatory dose of hCG
to PMSG-primed animals) receiving intrabursal injections of PBS
only or S or AS oligonucleotides.
trations, 300 and 1200 mM. Since 1200 mM did not add any
signi®cant bene®ts to the experiments in terms of altered
morphology or further decrease in ovulation rate, and 300
mM was without reproducible effect, 600 mM was chosen as
suitable concentration for the subsequent experiments.
The reduced expression of C/EBPa resulted in an impair-
ment of follicular function, making the follicles unable to
FIG. 4. Immunoblot demonstrating the content of C/EBPa in ova- respond properly to gonadotropins (PMSG, hCG) and subse-
ries 24 hr (a) and 48 hr (b) after PMSG. The ovaries were exposed
to sense (left lanes) or antisense (right lanes) oligonucleotides.
temic effects of AS treatment. The intrabursal injection
technique has previously been used for substances which
had the potential to interfere with the ovulatory process
(Reich et al., 1985), e.g., inhibitors of prostaglandin synthe-
sis. The effect of these inhibitors was limited from the time
of the ovulatory LH surge to follicular rupture, a time period
of approximately 12 hr in the rat. The present study is there-
fore the ®rst, to our knowledge, to demonstrate an effect of
a single, local deposition of substances on a cellular process
in the ovary.
The concentration and amount of AS and S (600 mM, 20
ml per ovary) used in the present study was calculated to
give an average concentration of 1±5 mM in the ovarian
tissue if the oligonucleotides were evenly distributed. This
concentration range has been used to demonstrate speci®c
effects in several in vitro systems (Stein and Krieg, 1994). FIG. 6. The protein content of c-myc in ovaries 48 hr after PMSG.
The ovaries were exposed to S (left lane) or AS (right lane).In our initial experiments, we also used two other concen-
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roles of c-myc and C/EBPawere demonstrated in differenti-
ating preadipocytes in vitro. In the latter study, the expres-
sion of c-myc decreased the level of C/EBPa and prevented
adipogenesis. This blockage of differentiation by c-myc was
overcome by an enforced expression of C/EBPa. Our results
support an antagonistic relationship between these tran-
scription factors in the rat ovary in vivo, similar to that
described above for differentiating adipocytes in vivo.
We have previously demonstrated that C/EBPa is regulated
by hormones during the later stages of folliculogenesis, i.e.,
from the antral to the PO stage (Piontkewitz et al., 1993). It
was recently demonstrated that the insulin-like growth factor
I (IGF-I) was regulated in human liver cells by members of
the C/EBP family of transcription factors (Nolten et al., 1994).
Their data suggested that both C/EBPa and C/EBPb were
involved in the regulation of the human IGF-I gene. Interest-
ingly, IGF-I was expressed in proliferating granulosa cells of
healthy, antral follicles in the rat ovary (Zhou et al., 1995).
Furthermore, this latter study demonstrated a speci®c expres-
sion of IGF-I in central/perilumenal granulosa cells of more
mature, antral follicles. In a previous study, a speci®c expres-
FIG. 7. The levels of mRNA for c-myc at 12, 24, and 48 hr after sion of C/EBPa was noticed in granulosa cells surrounding
PMSG in animals receiving intrabursal injections of PBS only or S the oocytes in antral follicles, prior to a more spread out
or AS oligonucleotides to C/EBPa. distribution of C/EBPa at later stages of follicular maturation
(Piontkewitz et al., 1993). However, further studies are
needed to examine an eventual regulation of IGF-I as well as
other target genes in the ovary by members of the C/EBP-quently to ovulate. The administration of AS resulted in an
attenuated expression of the C/EBPa protein at 24 and 48 family of transcription factors.
To our knowledge, this is the ®rst time that local admin-hr, although the difference between AS- and S-treated ani-
mals was less pronounced at the latter time point. This was istration of antisense oligonucleotides in vivo resulted in
an organ-speci®c attenuation of a transcription factor. Thisdemonstrated with both immunocytochemistry (Figs. 2 and
3) and immunoblotting (Fig. 4). In contrast, we were unable in vivo approach also allowed us to examine the biological
function of C/EBPa during follicular development and ovu-to detect differences at the mRNA level. Several previous
studies using antisense oligonucleotides have reported simi- lation. The results demonstrate a critical role for C/EBPa,
and this transcription factor seems to be a necessary compo-lar results with discrepancies between mRNA and protein
levels (Moats-Staats et al., 1993). This ®nding suggests that nent of the transcriptional machinery involved in the differ-
entiation of ovarian cells.the major effect of the antisense constructs in the present
study was at the translational level. However, another pos-
sibility is that the measured mRNA levels after AS repre-
sent a partially compensated state of expression due to a ACKNOWLEDGMENTS
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